City Therapeutics Raises $200 Million in Upsized US IPO
City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More news about United States of America
- Fed Chair Warsh Says US Is Seeing an Investment SurgeFed Chairman Kevin Warsh says there's a US investment surge thanks in part to sound macroeconomic policy and strong microeconomic foundations, calling it one of the global economy’s most important...
- Is JD Vance campaigning for the midterms … or 2028? – podcastThe US vice-president is following the Donald Trump playbook, attacking the Democrats, attempting to make jokes and even swearing more. Jonathan Freedland talks to Arwa Mahdawi about why Vance is m...
- Chilling details emerge of mass shooting plot targeting US Hindu templeIllinois authorities believe a 19-year-old man charged with planning a mass shooting at a Hindu temple in suburban Chicago entered the building’s car park on Sunday, hours before police arrested hi...
- Wall Street’s AI wobblesInvestors are dumping data centre bonds and abandoned listings are piling up
- US business leaders are waking up to the perils of plutopopulismCompanies wanted a president who would cut taxes and rules, they got one who has blown holes in free trade and global alliances
- Georgia race brings competing tax relief proposals - FOX 5 AtlantaGeorgia race brings competing tax relief proposals FOX 5 Atlanta
- Consul General of Greece in San Francisco Visits Seattle - The National HeraldConsul General of Greece in San Francisco Visits Seattle The National Herald
- South Georgia police chief booked into jail on theft charges - FOX 5 AtlantaSouth Georgia police chief booked into jail on theft charges FOX 5 Atlanta